Search Results - "Tadlaoui, K.O."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Safety and immunogenicity of the Rift Valley fever arMP-12 ΔNSm21/384 candidate vaccine in pregnant ewes by Boumart, Z., Bamouh, Z., Hamdi, J., Safini, N., Tadlaoui, K.O., Bettinger, G., Watts, D.M., Elharrak, M.

    Published in Vaccine: X (11-12-2020)
    “…•Rift Valley fever virus causes abortion, teratogenicity and mortality in domestic ruminants.•Safety and immunogenicity RVFV arMP-12ΔNSm21/384 vaccine was…”
    Get full text
    Journal Article
  2. 2

    Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves by Boumart, Z., Daouam, S., Bamouh, Z., Jazouli, M., Tadlaoui, K.O, Dungu, B., Bettinger, G., Watts, D.M., Elharrak, M.

    Published in Vaccine (14-03-2019)
    “…•RVF arMP-12ΔNSm21/384 vaccine virus was evaluated as a potential veterinary vaccine.•Vaccine virus infectivity titers in Vero cell were suitable for vaccine…”
    Get full text
    Journal Article